Ruigao Song

Ruigao Song

Auto-generated profile, based on publicly available information

Ruigao Song

State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Theriogenology
Verified
Journal Article
Closed access
RSRuigao Song
Ruigao Song
XYXiaolei Yao
Xiaolei Yao
LSLei Shi
Lei Shi
YRYoushe Ren
Youshe Ren
HZHui Zhao
Hui Zhao

1 June 2021 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
JYJing Yao
Jing Yao
YWYu Wang
Yu Wang
CCChunwei Cao
Chunwei Cao
RSRuigao Song
Ruigao Song
DBDengfeng Bi
Dengfeng Bi
JZJianguo Zhao
Jianguo Zhao
Gene therapy for curing congenital human diseases is promising, but the feasibility and safety need to be further evaluated. In this study, based on a pig model that carries the c.740T>C (L247S) mutation in MITF with an inheritance pattern and clinical pathology that mimics Waardenburg syndrome 2A (WS2A), we corrected the point mutation by the CRISPR-Cas9 system in the mutant fibroblast cells using single-stranded oligodeoxynucleotide (ssODN) and long donor plasmid DNA as the repair template. By using long donor DNA, precise correction of this point mutation was achieved. The corrected cells were then used as the donor cell for somatic cell nuclear transfer (SCNT) to produce piglets, which exhibited a successfully rescued phenotype of WS2A, including anophthalmia and hearing loss. Furthermore, engineered base editors (BEs) were exploited to make the correction in mutant porcine fibroblast cells and early embryos. The correction efficiency was greatly improved, whereas substantial off-targeting mutations were detected, raising a safety concern for their potential applications in gene therapy. Thus, we explored the possibility of precise correction of WS2A-causing gene mutation by the CRISPR-Cas9 system in a large-animal model, suggesting great prospects for its future applications in treating human genetic diseases.

27 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
RSRuigao Song
Ruigao Song
YWYu Wang
Yu Wang
QZQiantao Zheng
Qiantao Zheng
JYJing Yao
Jing Yao
CCChunwei Cao
Chunwei Cao
JZJianguo Zhao
Jianguo Zhao
Precise and simultaneous acquisition of multiple beneficial alleles in the genome to improve pig performance are pivotal for making elite breeders. Cytidine base editors (CBEs) have emerged as powerful tools for site-specific single nucleotide replacement. Here, we compare the editing efficiency of four CBEs in porcine embryonic cells and embryos to show that hA3A-BE3-Y130F and hA3A-eBE3-Y130F consistently results in higher base-editing efficiency and lower toxic effects to in vitro embryo development. We also show that zygote microinjection of hA3A-BE3-Y130F results in one-step generation of pigs (3BE pigs) harboring C-to-T point mutations, including a stop codon in CD163 and in MSTN and induce beneficial allele in IGF2 . The 3BE pigs showed improved growth performance, hip circumference, food conversion rate. Our results demonstrate that CBEs can mediate high throughput genome editing by direct embryo microinjection. Our approach allows immediate introduction of novel alleles for beneficial traits in transgene-free animals for pyramid breeding.

5 August 2026 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
HLHongxia Li
Hongxia Li
GZGuoqing Zhao
Guoqing Zhao
RZRuojun Zong
Ruojun Zong
JLJia Liu
Jia Liu
LHLiwei Huang
Liwei Huang
RSRuigao Song
Ruigao Song